Literature DB >> 22023333

Angiographically silent cystoid macular oedema secondary to paclitaxel therapy.

Constantine D Georgakopoulos1, Olga E Makri, Panagiotis Vasilakis, Artemis Exarchou.   

Abstract

Bilateral macular oedema is an uncommon side-effect of paclitaxel administration in oncological patients. We report the case of a 64-year-old man who presented with decreased visual acuity due to bilateral macular oedema after paclitaxel administration for lung cancer. Optical coherence tomography scans of both eyes revealed cystoid macular oedema. Fluorescein angiography demonstrated the unusual finding of the absence of localised retinal capillary leakage. Ketorolac eye drops and acetazolamide tablets were prescribed and one month later the cystoid macular oedema resolved with subsequent improvement in visual acuity. This case illustrates the unusual presentation of cystoid macular oedema induced by paclitaxel.
© 2011 The Authors. Clinical and Experimental Optometry © 2011 Optometrists Association Australia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22023333     DOI: 10.1111/j.1444-0938.2011.00672.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  9 in total

1.  Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report.

Authors:  Emma Bassi; Vera Loizzi; Claudio Furino; Rosa Martino; Giovanni Alessio; Cicinelli Ettore; Gennaro Cormio
Journal:  Mol Clin Oncol       Date:  2017-06-21

Review 2.  Cystoid macular oedema without leakage in fluorescein angiography: a literature review.

Authors:  Masood Naseripour; Sara Hemmati; Samira Chaibakhsh; Arzhang Gordiz; Leila Miri; Fatemeh Abdi
Journal:  Eye (Lond)       Date:  2022-09-10       Impact factor: 4.456

3.  Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema.

Authors:  Mark M Hassall; Nicholas Howard Andrew
Journal:  BMJ Case Rep       Date:  2016-04-19

Review 4.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

5.  Impaired retinal pigment epithelium in paclitaxel-induced macular edema: A case report.

Authors:  Chia-Hsin Shih; Yuan-Chieh Lee
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

6.  Intravitreal Ranibizumab Had Limited Effect on Cystoid Macular Edema Due to Albumin-Bound Paclitaxel: A Case Report and Literature Review.

Authors:  Suna Ye; Qiqi Fang; Jinyu Yao; Jianqiang Xing; Shibo Tang; Jacey Hongjie Ma
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

7.  Bilateral intermediate uveitis following treatment with paclitaxel in a patient with invasive ductal carcinoma of the breast.

Authors:  Michael Kvopka; Justine R Smith; Bogda Koczwara; Stewart R Lake
Journal:  Int J Retina Vitreous       Date:  2022-09-06

8.  Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy.

Authors:  Barbara Burgos-Blasco; Samuel Hernandez-Ruiz; Lorenzo Lopez-Guajardo; Juan Donate-Lopez
Journal:  Am J Ophthalmol Case Rep       Date:  2020-03-07

9.  Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.

Authors:  Mitsuru Otsubo; Reiko Kinouchi; Takayuki Kamiya; Akitoshi Yoshida
Journal:  J Med Case Rep       Date:  2021-07-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.